Reply to Erfan Ayubi and Saeid Safiri's Letter to the Editor re: R. Jeffrey Karnes, Voleak Choeurng, Ashley E. Ross, et al. Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2017.03.036. Methodological Issues

被引：0

作者：

Trocka, Bruce J. ^{[1
,2
]}

Karnes, R. Jeffrey

机构：

[1] Johns Hopkins Sch Med, James Buchanan Brady Urol Inst, Baltimore, MD USA

[2] Johns Hopkins Sch Med, Dept Urol, Baltimore, MD USA

来源：

EUROPEAN UROLOGY | 2017年 / 72卷 / 06期

关键词：

PERFORMANCE;

D O I：

10.1016/j.eururo.2017.05.030

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E158 / E159

页数：2

共 22 条

[1] Re: R. Jeffrey Karnes, Voleak Choeurng, Ashley E. Ross, et al. Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features. Eur Urol. In press. https://doi.org/10.1016/j.eururo. 2017.03.036
Ayubi, Erfan
Safiri, Saeid
[J]. EUROPEAN UROLOGY, 2017, 72 (06) : E157 - E157
[2] Reply to Kentaro Inamura's Letter to the Editor re: Mingxiao Feng, Andres Matoso, Gabriel Epstein, et al. Identification of Lineage-specific Transcriptional Factordefined Molecular Subtypes in Small Cell Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j. eururo.2023.05.023
Feng, Mingxiao
Matoso, Andres
Epstein, Gabriel
Fong, Megan
Park, Yong Hyun
Gabrielson, Andrew
Patel, Sunil
Czerniak, Bagdan
Comperat, Eva
Hoffman-Censits, Jeannie
Kates, Max
Kim, Seungchan
McConkey, David
Choi, Woonyoung
[J]. EUROPEAN UROLOGY, 2024, 85 (04) : e122 - e123
[3] Reply to Mauricio Plata, Cesar Diaz Ritter, and Nicolas Badillo's Letter to the Editor re: Gabriela Ilie, Ricardo Rendon, Ross Mason, et al. A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.02.009
Ilie, Gabriela
Rutledge, Robert David Harold
[J]. EUROPEAN UROLOGY, 2023, 84 (01) : E26 - E27
[4] Reply to Hiten D. Patel and Mohamad E. Allaf's Letter to the Editor re: Maxine Sun, Andreas Becker, Zhe Tian, et al. Management of Localized Kidney Cancer: Calculating Cancer-specific Mortality and Competing Risks of Death for Surgery and Nonsurgical Management. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.03.034
Sun, Maxine
Karakiewicz, Pierre I.
Quoc-Dien Trinh
[J]. EUROPEAN UROLOGY, 2013, 64 (05) : E107 - E108
[5] Reply to Kamal Kant Sahu's Letter to the Editor re: Veerle H. Groen, Karin Haustermans, Floris J. Pos, et al. Patterns of Failure Following External Beam Radiotherapy With or Without an Additional Focal Boost in the Randomized Controlled FLAME Trial for Localized Prostate Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.12.012
Kerkmeijer, Linda G. W.
Pos, Floris J.
van der Heide, Uulke A.
Israel, Bas
Draulans, Cedric
Haustermans, Karin
[J]. EUROPEAN UROLOGY, 2022, 81 (06) : E147 - E148
[6] Reply to Sungeun Kim, Jae Il Shin, and Jonathan Evan Shoag's Letter to the Editor re: Luca F. Valle, Eric J. Lehrer, Daniela Markovic, et al. A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER). Eur Urol. In press. https://doi.org/10.1016/j. eururo.2020.11.010
Valle, Luca F.
Kishan, Amar U.
[J]. EUROPEAN UROLOGY, 2021, 80 (01) : E15 - E16
[7] Kenta Ushida, Miho Shimizu, and Ryo Momosaki's Letter to the Editor re: Logan G. Briggs, Chanan Reitblat, Paul A. Bain, et al. Prehabilitation Exercise Before Urologic Cancer Surgery: A Systematic and Interdisciplinary Review. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.05.015. Strategies for Effective Prehabilitation in Urologic Cancer Reply
Briggs, Logan G.
Parke, Sara
Bain, Paul A.
Psutka, Sarah P.
[J]. EUROPEAN UROLOGY, 2021, 80 (06) : E141 - E142
[8] Reply to Anwar R. Padhani, Frederic LeCouvet, Giuseppe Petralia, and Dow-Mu Koh's Letter to the Editor re: Alonso Garcia-Ruiz, Carlos Macarro, Francesca Zacchi, et al. Whole-body Magnetic Resonance Imaging as a Treatment Response Biomarker in Castration resistant Prostate Cancer with Bone Metastases: The iPROMET Clinical Trial. Eur Urol. In press. https://doi.org/10.1016/j. eururo.2024.02.016
Garcia-Ruiz, Alonso
Macarro, Carlos
Mateo, Joaquin
Perez-Lopez, Raquel
[J]. EUROPEAN UROLOGY, 2024, 86 (03) : e69 - e70
[9] Reply to Alessia Cimadamore, Liang Cheng, Antonio Lopez-Beltran, Marina Scarpelli, and Rodolfo Montironi's Letter to the Editor re: Scott Wilkinson, Huihui Ye, Fatima Karzai, et al. Nascent Prostate Cancer Hetero- geneity Drives Evolution and Resistance to Intense Hormonal Therapy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.03.0 09: Focus on Intraductal Carcinoma of the Prostate
Wilkinson, Scott
Ye, Huihui
Lis, Rosina T.
Sowalsky, Adam G.
[J]. EUROPEAN UROLOGY, 2021, 80 (03) : E83 - E84
[10] Reply to Gopa Iyer, Bernard H. Bochner, Eliezer M. Van Allen, David B. Solit, and Jonathan E. Rosenberg's Letter to the Editor re: Russell EN Becker, Alexa R. Meyer, Aaron Brant, et al. Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.07.016
Becker, Russell E. N.
Baras, Alex
Bivalacqua, Trinity J.
[J]. EUROPEAN UROLOGY, 2021, 79 (02) : E58 - E59

← 1 2 3 →